[Federal Register Volume 70, Number 25 (Tuesday, February 8, 2005)]
[Notices]
[Page 6708]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-2355]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Board of Scientific Advisors.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Board of Scientific 
Advisors.
    Date: March 7-8, 2005.
    Time: March 7, 2005, 8 a.m. to 10:30 a.m.
    Agenda: Joint meeting of the NCI Board of Scientific Advisors 
and NCI Board of Scientific Counselors; Report of the Director, NCI; 
Legislative Update; and Ethics Overview.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Time: March 7, 2005, 10:30 a.m. to 6 p.m.
    Agenda: Ongoing and New Business; Reports of Program Review 
Group(s); and Budget Presentation; Reports of Special Initiatives; 
RFA and RFP Concept Reviews; and Scientific Presentations.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Time: March 8, 2005, 8:30 a.m. to 1 p.m.
    Agenda: Reports of Special Initiatives; RFA and RFP Concept 
Reviews; and Scientific Presentations.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Paulette S. Gray, PhD, Executive Secretary, 
Acting Director, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Boulevard, 
8th Floor, Rm. 8001, Bethesda, MD 20892, 301-496-5147.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/bsa.htm htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 2, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-2355 Filed 2-7-05; 8:45 am]
BILLING CODE 4140-01-M